JMCR: Highlight

When severe anemia reveals a multisystem diagnosis.

Published in Biomedical Research

JMCR: Highlight
Like

Share this post

Choose a social network to share with, or copy the URL to share elsewhere

This is a representation of how your post may appear on social media. The actual post will vary between social networks

Explore the Research

BioMed Central
BioMed Central BioMed Central

Autoimmune pernicious anemia in clinically diagnosed Bardet–Biedl syndrome: a case report and brief literature review

Background Bardet–Biedl syndrome is a rare autosomal recessive ciliopathy that may be diagnosed clinically in resource-limited settings where molecular testing is unavailable. Autoimmune pernicious anemia has been rarely described in association with BBS, and its relationship to BBS-related immune dysregulation remains uncertain. Case presentation We report an 18-year-old Pakistani woman of Pashtun ethnicity from a consanguineous family who presented with four months of progressive fatigue, weakness, pallor, and exertional dyspnea. Evaluation revealed severe macrocytic anemia due to vitamin B12 deficiency, with positive anti-intrinsic factor and anti-parietal cell antibodies confirming autoimmune pernicious anemia. Further history identified childhood-onset retinal dystrophy progressing to blindness, postaxial polydactyly, developmental delay, primary amenorrhea, bilaterally small kidneys, diabetes mellitus, parental consanguinity, and a similarly affected sibling. She fulfilled all six major and two minor clinical diagnostic criteria for Bardet–Biedl syndrome; molecular confirmation could not be arranged because of resource limitations. She improved after packed red cell transfusion and intramuscular cyanocobalamin and was discharged on lifelong vitamin B12 replacement. Conclusions This case documents a rare co-occurrence of autoimmune pernicious anemia in a patient clinically fulfilling all major criteria for Bardet–Biedl syndrome in a resource-limited setting where molecular confirmation was unavailable. While a single clinical case cannot establish causality or exclude overlapping conditions, the observation is biologically plausible in light of emerging evidence linking ciliary dysfunction to immune dysregulation. Clinicians managing patients with suspected or confirmed BBS should maintain vigilance for autoimmune pernicious anemia when evaluating unexplained macrocytic anemia or vitamin B12 deficiency.

An 18-year-old woman presenting with profound macrocytic anemia was found to have antibody-confirmed pernicious anemia—and a constellation of findings fulfilling all six major clinical criteria for Bardet–Biedl syndrome.

Imran and Ali describe a Pakistani woman from a consanguineous family who presented with four months of progressive fatigue, weakness, pallor, and exertional dyspnea. Her hemoglobin was 4.7 g/dL, with macrocytosis, vitamin B12 deficiency, macro-ovalocytes, and hypersegmented neutrophils. Positive anti-intrinsic factor and anti-parietal cell antibodies supported the diagnosis of autoimmune pernicious anemia.

A more detailed history revealed childhood-onset retinal dystrophy progressing to blindness, postaxial polydactyly, obesity, developmental delay, primary amenorrhea, diabetes mellitus, bilateral small kidneys, albuminuria, and a similarly affected sibling. Together, these findings fulfilled all six major and two minor clinical criteria for Bardet–Biedl syndrome.

Molecular confirmation was unavailable because of financial and logistical limitations. The case therefore illustrates the continuing value of established clinical diagnostic criteria in settings where genetic testing cannot readily be obtained.

The co-occurrence of Bardet–Biedl syndrome and autoimmune pernicious anemia is rare. Emerging evidence suggests that ciliary dysfunction may influence immune regulation, but this single case cannot establish a causal relationship. The association remains biologically plausible and hypothesis-generating.

The patient improved following packed red-cell transfusion and intramuscular cyanocobalamin and was discharged on lifelong vitamin B12 replacement with multidisciplinary follow-up.

Clinical Take-Home Message

In patients with Bardet–Biedl syndrome or a compatible ciliopathy phenotype, macrocytic anemia and vitamin B12 deficiency should prompt evaluation for pernicious anemia rather than being attributed automatically to nutritional deficiency or chronic disease. Early recognition and treatment may prevent irreversible neurologic complications.

Reference

Imran J, Ali M. Autoimmune pernicious anemia in clinically diagnosed Bardet–Biedl syndrome: a case report and brief literature review. Journal of Medical Case Reports. 2026.
https://doi.org/10.1186/s13256-026-06593-9

Follow the Topic

Biomedical Research
Life Sciences > Health Sciences > Biomedical Research